⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAF News
bioAffinity Technologies, Inc. Common Stock
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung
businesswire.com
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy
businesswire.com
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW